ATM mutations in the 155 patients in the CLL cohort
Tumor ID . | Sequence change . | Protein change . | Present in diagnostic sample . | ATM function . | IGVH mutation status and family . | TFS, mo . | OS, mo . | Refractory to Flu/Chl . |
---|---|---|---|---|---|---|---|---|
Tumors with 2 mutant ATM alleles | ||||||||
77* | 1058DelGT | Truncated protein | Yes | Defective | 99%, VH1-2 | 0 | 83† | Yes |
77* | 5224G/C | A1742P | Yes | Defective | 99%, VH1-2 | 0 | 83† | Yes |
96* | 2929Ins9 | Inframe insertion | Yes | Defective | 96%, VH4-61 | 33 | 79 | Yes |
96* | 5041A/G | I1681V | Yes | Defective | 96%, VH4-61 | 33 | 79 | Yes |
96* | 5044G/T | D1682Y | Yes | Defective | 96%, VH4-61 | 33 | 79 | Yes |
11* | 5821G/C | V1941L | Not known | Defective | 98%, VH3-15 | 108 | 156† | Yes |
11* | 7313C/A | T2438K | Not known | Defective | 98%, VH3-15 | 108 | 156† | Yes |
11* | 8833Del34 | Truncated protein | Not known | Defective | 98%, VH3-15 | 108 | 156† | Yes |
Tumors with 1 mutant ATM allele and loss of the second allele | ||||||||
57* | 2308G/T | Truncated protein | Not known | Partial defect | 97%, VH4-59 | 76 | 101† | No |
15* | 7047C/G | C2349W | Not known | Defective | 100%, VH1-69 | 40 | 75 | Yes |
07* | 8600G/A | G2867E | Yes | Defective | 99%, VH3-11 | 0 | 96 | Yes |
152* | 8839A/T | T2946S | At 1 year§ | Defective | 99%, VH1-6 | 35 | 79† | No |
Tumors with 1 mutant ATM allele and 1 wild-type ATM allele | ||||||||
75 | 1009C/A | R337S | Yes | Defective | 98%, VH3-30 | 0 | 39 | Yes |
69 | 6815DelA | Truncated protein | Not known | Defective | 100%, VH3-15 | 39 | 72† | No |
119 | 9022C/T | R3008C | Not known | Defective | 97%, VH3-64 | 36 | 47† | No |
93 | 5290del C | Truncated protein | Yes | Defective | 100%, VH5-51 | 26† | 26† | NT |
92 | 5980A/G | K1994E | Yes | Partial defect | 99%, VH1-69 | 24† | 24 | NT |
124‡ | 5228C/T | T1743I | Not known | Partial defect | 85%, VH3-15 | 48† | 48† | NT |
84‡ | 5821G/C | V1941L | Yes | Partial defect | 93%, VH3-7 | 14 | 17 | Yes |
27 | 3383A/G | Q1127R | Not known | Normal | 99%, VH3-21 | 0 | 77 | Yes |
113 | 3964C/A | L1322F | Not known | Normal | 91%, VH3-7 | 24† | 24 | NT |
147 | IVS16-10T/G | Exon skip | Not known | Not done | 94%, VH5-51 | NA | NA | NA |
81 | 5882A/G | Y1961C | Not known | Not done | 93%, VH3-15 | 36† | 36† | NT |
Tumor ID . | Sequence change . | Protein change . | Present in diagnostic sample . | ATM function . | IGVH mutation status and family . | TFS, mo . | OS, mo . | Refractory to Flu/Chl . |
---|---|---|---|---|---|---|---|---|
Tumors with 2 mutant ATM alleles | ||||||||
77* | 1058DelGT | Truncated protein | Yes | Defective | 99%, VH1-2 | 0 | 83† | Yes |
77* | 5224G/C | A1742P | Yes | Defective | 99%, VH1-2 | 0 | 83† | Yes |
96* | 2929Ins9 | Inframe insertion | Yes | Defective | 96%, VH4-61 | 33 | 79 | Yes |
96* | 5041A/G | I1681V | Yes | Defective | 96%, VH4-61 | 33 | 79 | Yes |
96* | 5044G/T | D1682Y | Yes | Defective | 96%, VH4-61 | 33 | 79 | Yes |
11* | 5821G/C | V1941L | Not known | Defective | 98%, VH3-15 | 108 | 156† | Yes |
11* | 7313C/A | T2438K | Not known | Defective | 98%, VH3-15 | 108 | 156† | Yes |
11* | 8833Del34 | Truncated protein | Not known | Defective | 98%, VH3-15 | 108 | 156† | Yes |
Tumors with 1 mutant ATM allele and loss of the second allele | ||||||||
57* | 2308G/T | Truncated protein | Not known | Partial defect | 97%, VH4-59 | 76 | 101† | No |
15* | 7047C/G | C2349W | Not known | Defective | 100%, VH1-69 | 40 | 75 | Yes |
07* | 8600G/A | G2867E | Yes | Defective | 99%, VH3-11 | 0 | 96 | Yes |
152* | 8839A/T | T2946S | At 1 year§ | Defective | 99%, VH1-6 | 35 | 79† | No |
Tumors with 1 mutant ATM allele and 1 wild-type ATM allele | ||||||||
75 | 1009C/A | R337S | Yes | Defective | 98%, VH3-30 | 0 | 39 | Yes |
69 | 6815DelA | Truncated protein | Not known | Defective | 100%, VH3-15 | 39 | 72† | No |
119 | 9022C/T | R3008C | Not known | Defective | 97%, VH3-64 | 36 | 47† | No |
93 | 5290del C | Truncated protein | Yes | Defective | 100%, VH5-51 | 26† | 26† | NT |
92 | 5980A/G | K1994E | Yes | Partial defect | 99%, VH1-69 | 24† | 24 | NT |
124‡ | 5228C/T | T1743I | Not known | Partial defect | 85%, VH3-15 | 48† | 48† | NT |
84‡ | 5821G/C | V1941L | Yes | Partial defect | 93%, VH3-7 | 14 | 17 | Yes |
27 | 3383A/G | Q1127R | Not known | Normal | 99%, VH3-21 | 0 | 77 | Yes |
113 | 3964C/A | L1322F | Not known | Normal | 91%, VH3-7 | 24† | 24 | NT |
147 | IVS16-10T/G | Exon skip | Not known | Not done | 94%, VH5-51 | NA | NA | NA |
81 | 5882A/G | Y1961C | Not known | Not done | 93%, VH3-15 | 36† | 36† | NT |
Flu indicates fludarabine; Chl, chlorambucil; OS, overall survival; TFS, treatment-free survival; ND, not done; NT, not treated; NA, not available.
Patients with predicted loss of both functional ATM alleles
Treatment or death, respectively, has not occurred
Patients with ATM and TP53 mutations
See “ATM mutations are present early in disease ontogenesis and usually at diagnosis”